234 related articles for article (PubMed ID: 27283945)
1. Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications.
Baghbaderani BA; Syama A; Sivapatham R; Pei Y; Mukherjee O; Fellner T; Zeng X; Rao MS
Stem Cell Rev Rep; 2016 Aug; 12(4):394-420. PubMed ID: 27283945
[TBL] [Abstract][Full Text] [Related]
2. Array-comparative genomic hybridization characterization of human pluripotent stem cells.
Elliott AM; Elliott KA; Kammesheidt A
Methods Mol Biol; 2012; 873():261-7. PubMed ID: 22528361
[TBL] [Abstract][Full Text] [Related]
3. Rapid and Efficient Generation of Transgene-Free iPSC from a Small Volume of Cryopreserved Blood.
Zhou H; Martinez H; Sun B; Li A; Zimmer M; Katsanis N; Davis EE; Kurtzberg J; Lipnick S; Noggle S; Rao M; Chang S
Stem Cell Rev Rep; 2015 Aug; 11(4):652-65. PubMed ID: 25951995
[TBL] [Abstract][Full Text] [Related]
4. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
[TBL] [Abstract][Full Text] [Related]
5. Can cord blood banks transform into induced pluripotent stem cell banks?
Zhou H; Rao MS
Cytotherapy; 2015 Jun; 17(6):756-764. PubMed ID: 25770678
[TBL] [Abstract][Full Text] [Related]
6. Cytoskeletal Expression and Remodeling in Pluripotent Stem Cells.
Boraas LC; Guidry JB; Pineda ET; Ahsan T
PLoS One; 2016; 11(1):e0145084. PubMed ID: 26771179
[TBL] [Abstract][Full Text] [Related]
7. Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration.
Nam Y; Rim YA; Jung SM; Ju JH
Stem Cell Res Ther; 2017 Jan; 8(1):16. PubMed ID: 28129782
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
[TBL] [Abstract][Full Text] [Related]
9. Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system.
Xu J; Yu L; Guo J; Xiang J; Zheng Z; Gao D; Shi B; Hao H; Jiao D; Zhong L; Wang Y; Wu J; Wei H; Han J
Stem Cell Res Ther; 2019 Jun; 10(1):193. PubMed ID: 31248457
[TBL] [Abstract][Full Text] [Related]
10. Deriving retinal pigment epithelium (RPE) from induced pluripotent stem (iPS) cells by different sizes of embryoid bodies.
Muñiz A; Ramesh KR; Greene WA; Choi JH; Wang HC
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741607
[TBL] [Abstract][Full Text] [Related]
11. Early prediction of the differentiation potential during the formation of human iPSC-derived embryoid bodies.
Guo NN; Liu LP; Zhang YX; Cai YT; Guo Y; Zheng YW; Li YM
Biochem Biophys Res Commun; 2019 Aug; 516(3):673-679. PubMed ID: 31248595
[TBL] [Abstract][Full Text] [Related]
12. Illustrating the potency of current Good Manufacturing Practice-compliant induced pluripotent stem cell lines as a source of multiple cell lineages using standardized protocols.
Rao MS; Pei Y; Garcia TY; Chew S; Kasai T; Hisai T; Taniguchi H; Takebe T; Lamba DA; Zeng X
Cytotherapy; 2018 Jun; 20(6):861-872. PubMed ID: 29793831
[TBL] [Abstract][Full Text] [Related]
13. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
[TBL] [Abstract][Full Text] [Related]
14. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
[TBL] [Abstract][Full Text] [Related]
15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of human iPSC line from CD34
Fernandes S; Talwadekar M; Agarwal R; Nair V; Kale V; Limaye L
Stem Cell Res; 2017 Jan; 18():60-63. PubMed ID: 28395807
[TBL] [Abstract][Full Text] [Related]
17. Dental pulp of the third molar: a new source of pluripotent-like stem cells.
Atari M; Gil-Recio C; Fabregat M; García-Fernández D; Barajas M; Carrasco MA; Jung HS; Alfaro FH; Casals N; Prosper F; Ferrés-Padró E; Giner L
J Cell Sci; 2012 Jul; 125(Pt 14):3343-56. PubMed ID: 22467856
[TBL] [Abstract][Full Text] [Related]
18. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells.
Kim K; Zhao R; Doi A; Ng K; Unternaehrer J; Cahan P; Huo H; Loh YH; Aryee MJ; Lensch MW; Li H; Collins JJ; Feinberg AP; Daley GQ
Nat Biotechnol; 2011 Nov; 29(12):1117-9. PubMed ID: 22119740
[TBL] [Abstract][Full Text] [Related]
19. Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies.
Hatani T; Miki K; Yoshida Y
Methods Mol Biol; 2018; 1816():79-92. PubMed ID: 29987812
[TBL] [Abstract][Full Text] [Related]
20. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
